Regulatory News
Wednesday, November 16, 2016
Japan sets 50 pct price cut for Opdivo cancer drug: Ono Pharma
Nov 16 (Reuters) - A Japanese health ministry council has
approved a 50 percent cut in the price of Opdivo, a costly
immune system-boosting cancer drug produced by Bristol Myers
Squibb Co and...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment